Your browser doesn't support javascript.
loading
Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant.
van Nuland, Merel; Janssen, Julie M; van Hoek, Bart; Rosing, Hilde; Beijnen, Jos H; Bergman, André M.
Afiliação
  • van Nuland M; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: m.v.nuland@nki.nl.
  • Janssen JM; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Hoek B; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Rosing H; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Ut
  • Bergman AM; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Clin Genitourin Cancer ; 17(5): e893-e896, 2019 10.
Article em En | MEDLINE | ID: mdl-31248829

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Idioma: En Ano de publicação: 2019 Tipo de documento: Article